Oliver Luxxe Assets LLC Amgen Inc Transaction History

Oliver Luxxe Assets LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 10, 2019	SELL	$166.7 - $195.41 $810,495 - $950,083	-4,862 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$180.87 - $203.88 $9,405 - $10,601	-52 Reduced 1.06%	4,862 $924,000
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $3,568 - $4,165	20 Added 0.41%	4,914 $957,000
Q3 2018 Oct 10, 2018	SELL	$185.29 - $208.89 $167,131 - $188,418	-902 Reduced 15.56%	4,894 $998,000
Q1 2018 Apr 17, 2018	SELL	$169.43 - $198.0 $15,079 - $17,622	-89 Reduced 1.51%	5,796 $988,000
Q4 2017 Jan 16, 2018	BUY	$168.79 - $188.59 $25,318 - $28,288	150 Added 2.62%	5,885 $1.02 Million
Q3 2017 Oct 23, 2017	BUY	$167.29 - $191.0 $959,408 - $1.1 Million	5,735	5,735 $1.07 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

Stay updated on Oliver Luxxe Assets LLC with notifications on news.